짐머 바이오메트 홀딩스(ZBH)는 NYSE에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $95.70 (+1.54%), 시가총액 $16.65B, PER (주가수익비율) 22.30, 52주 최저~최고 $79.58 ~ $107.71.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformiti
짐머 바이오메트 홀딩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
짐머 바이오메트 홀딩스의 현재 주가는 $95.70 (+1.54%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
짐머 바이오메트 홀딩스의 시가총액은 약 $16.65B입니다. PER은 22.30입니다.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, suc